<p>Join Head of US Capital Markets Research, Mark Odendahl and biotech analysts Brian Abrahams and Gregory Renza, as they explore the dynamic biotech sector landscape in H2 2023. </p>

Join Head of US Capital Markets Research, Mark Odendahl and biotech analysts Brian Abrahams and Gregory Renza, as they explore the dynamic biotech sector landscape in H2 2023.

Biotech Halftime Report: A Winding Road Ahead

Markets and sectors are transforming at a speed never seen before. Industries in Motion – a new serialized podcast from RBC Capital Markets – delivers highly differentiated insights and intelligence that looks at where now meets next, turning today’s faster-moving trends into tomorrow’s opportunities.

Disclaimer: https://www.rbccm.com/en/policies-disclaimers.page

Business

News

Investing

Business News

Markets and sectors are transforming at a speed never seen before. Industries in Motion – a new serialized podcast from RBC Capital Markets – delivers highly differentiated insights and intelligence that looks at where now meets next, turning today’s faster-moving trends into tomorrow’s opportunities. Disclaimer: https://www.rbccm.com/en/policies-disclaimers.page

Share Biotech Halftime Report: A Winding Road Ahead

Sign up to save your podcasts

Biotech Halftime Report: A Winding Road Ahead

Biotech Halftime Report: A Winding Road Ahead

More shows like Industries in Motion

RBC's Markets in Motion

Pathfinders in Biopharma

Powering Sustainable Ideas

Strategic Alternatives

Macro Minutes